Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of blood and blood-forming tissues (HP:0001871)help
Grandparent Node:
expand
Neoplasm by anatomical site (HP:0011793)help
Parent Node:
expand
Hematological neoplasm (HP:0004377)help
..Starting node
..expand
Lymphoma (HP:0002665)help
Term ID: 2665
Name: Lymphoma
Synonym: Cancer of lymphatic system
Definition: A cancer originating in lymphocytes and presenting as a solid tumor of lymhpoid cells.
Comments:
Reference: HP:0002665
Genes and Diseases:
 
       Child Nodes:
........expandPulmonary lymphoma (HP:0011953) help
........expandHodgkin lymphoma (HP:0012189) help
........expandNon-Hodgkin lymphoma (HP:0012539) help
................... HP:0012190 T-cell lymphoma
................... HP:0012191 B-cell lymphoma
................... HP:0030069 Primary central nervous system lymphoma
................... HP:0030080 Burkitt lymphoma
........expandGastric lymphoma (HP:0045038) help

 Sister Nodes: 
..expandLeukemia (HP:0001909) help
..expandLymphoproliferative disorder (HP:0005523) help
..expandMalignant eosinophil proliferation (HP:0006782) help
..expandMultiple myeloma (HP:0006775) help
..expandMyelodysplasia (HP:0002863) help
..expandPlasmacytoma (HP:0011857) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0002665HP:0002665Lymphoma0ATM CL E G H472208900Ataxia-telangiectasia syndrome208900C0004135OMIM11324795607585
HP:0002665HP:0002665Lymphoma0BCL2 CL E G H596545Adducted thumbs Dundar typeORPHA13990151430
HP:0002665HP:0002665Lymphoma0BCL6 CL E G H604545Adducted thumbs Dundar typeORPHA111001109565
HP:0002665HP:0002665Lymphoma0BLM CL E G H641210900Bloom syndrome210900C0005859OMIM11311058604610
HP:0002665HP:0002665Lymphoma0CASP10 CL E G H843605027Non-Hodgkin lymphoma605027C0024305OMIM191500601762
HP:0002665HP:0002665Lymphoma0CD19 CL E G H930240500Common variable immunodeficiency 2240500C3150354OMIM1101633107265
HP:0002665HP:0002665Lymphoma0CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA12431787600160
HP:0002665HP:0002665Lymphoma0CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA121316627604373
HP:0002665HP:0002665Lymphoma0CR2 CL E G H1380240500Common variable immunodeficiency 2240500C3150354OMIM1192336120650
HP:0002665HP:0002665Lymphoma0HLA-DRB1 CL E G H3123545Adducted thumbs Dundar typeORPHA1264948142857
HP:0002665HP:0002665Lymphoma0ICOS CL E G H29851240500Common variable immunodeficiency 2240500C3150354OMIM165351604558
HP:0002665HP:0002665Lymphoma0IGH CL E G H3492545Adducted thumbs Dundar typeORPHA15477146910
HP:0002665HP:0002665Lymphoma0ITK CL E G H3702613011Lymphoproliferative syndrome 1613011C3552634OMIM1146171186973
HP:0002665HP:0002665Lymphoma0KRAS CL E G H3845614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1456407190070
HP:0002665HP:0002665Lymphoma0LIG4 CL E G H398199812ORPHA1406601601837
HP:0002665HP:0002665Lymphoma0LYST CL E G H1130167ORPHA11021968606897
HP:0002665HP:0002665Lymphoma0MAGT1 CL E G H84061300853Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia300853C3275445OMIM11528880300715
HP:0002665HP:0002665Lymphoma0MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA186973164785
HP:0002665HP:0002665Lymphoma0MLH1 CL E G H4292276300Turcot syndrome276300C0265325OMIM112037127120436
HP:0002665HP:0002665Lymphoma0MSH2 CL E G H4436276300Turcot syndrome276300C0265325OMIM112647325609309
HP:0002665HP:0002665Lymphoma0MSH6 CL E G H2956276300Turcot syndrome276300C0265325OMIM16027329600678
HP:0002665HP:0002665Lymphoma0MYD88 CL E G H461533226ORPHA177562602170
HP:0002665HP:0002665Lymphoma0NBN CL E G H4683251260Microcephaly, normal intelligence and immunodeficiency251260C0398791OMIM11487652602667
HP:0002665HP:0002665Lymphoma0NRAS CL E G H4893614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1147989164790
HP:0002665HP:0002665Lymphoma0PMS2 CL E G H5395276300Turcot syndrome276300C0265325OMIM13639122600259
HP:0002665HP:0002665Lymphoma0PNP CL E G H4860613179Purine-nucleoside phosphorylase deficiency613179C0268125OMIM1347892164050
HP:0002665HP:0002665Lymphoma0PRF1 CL E G H5551605027Non-Hodgkin lymphoma605027C0024305OMIM11849360170280
HP:0002665HP:0002665Lymphoma0RAD54B CL E G H25788605027Non-Hodgkin lymphoma605027C0024305OMIM1217228604289
HP:0002665HP:0002665Lymphoma0RAD54L CL E G H8438605027Non-Hodgkin lymphoma605027C0024305OMIM159826603615
HP:0002665HP:0002665Lymphoma0RB1 CL E G H5925180200Retinoblastoma180200C0035335OMIM111139884614041
HP:0002665HP:0002665Lymphoma0RUNX1 CL E G H861601399Familial platelet disorder with associated myeloid malignancy601399C1832388OMIM110510471151385
HP:0002665HP:0002665Lymphoma0SH2D1A CL E G H40682442ORPHA113110820300490
HP:0002665HP:0002665Lymphoma0SH2D1A CL E G H4068308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM113110820300490
HP:0002665HP:0002665Lymphoma0TNFRSF13B CL E G H23495240500Common variable immunodeficiency 2240500C3150354OMIM15018153604907
HP:0002665HP:0002665Lymphoma0TNFRSF13C CL E G H115650240500Common variable immunodeficiency 2240500C3150354OMIM1317755606269
HP:0002665HP:0002665Lymphoma0TP53 CL E G H7157524Acute megakaryoblastic leukemiaC0023462ORPHA154111998191170
HP:0002665HP:0002665Lymphoma0XIAP CL E G H3312442ORPHA199592300079
HP:0002665HP:0002665Lymphoma0XIAP CL E G H331308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM199592300079
HP:0002665HP:0002665Lymphoma0XRCC4 CL E G H751899812ORPHA11512831194363
HP:0002665HP:0002665Lymphoma1ATM CL E G H472208900Ataxia-telangiectasia syndrome208900C0004135OMIM11324795607585
HP:0002665HP:0002665Lymphoma1BCL2 CL E G H596545Adducted thumbs Dundar typeORPHA13990151430
HP:0002665HP:0002665Lymphoma1BCL6 CL E G H604545Adducted thumbs Dundar typeORPHA111001109565
HP:0002665HP:0002665Lymphoma1BLM CL E G H641210900Bloom syndrome210900C0005859OMIM11311058604610
HP:0002665HP:0002665Lymphoma1CASP10 CL E G H843605027Non-Hodgkin lymphoma605027C0024305OMIM191500601762
HP:0002665HP:0002665Lymphoma1CD19 CL E G H930240500Common variable immunodeficiency 2240500C3150354OMIM1101633107265
HP:0002665HP:0002665Lymphoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA12431787600160
HP:0002665HP:0002665Lymphoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA121316627604373
HP:0002665HP:0002665Lymphoma1CR2 CL E G H1380240500Common variable immunodeficiency 2240500C3150354OMIM1192336120650
HP:0002665HP:0002665Lymphoma1HLA-DRB1 CL E G H3123545Adducted thumbs Dundar typeORPHA1264948142857
HP:0002665HP:0002665Lymphoma1ICOS CL E G H29851240500Common variable immunodeficiency 2240500C3150354OMIM165351604558
HP:0002665HP:0002665Lymphoma1IGH CL E G H3492545Adducted thumbs Dundar typeORPHA15477146910
HP:0002665HP:0002665Lymphoma1ITK CL E G H3702613011Lymphoproliferative syndrome 1613011C3552634OMIM1146171186973
HP:0002665HP:0002665Lymphoma1KRAS CL E G H3845614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1456407190070
HP:0002665HP:0002665Lymphoma1LIG4 CL E G H398199812ORPHA1406601601837
HP:0002665HP:0002665Lymphoma1LYST CL E G H1130167ORPHA11021968606897
HP:0002665HP:0002665Lymphoma1MAGT1 CL E G H84061300853Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia300853C3275445OMIM11528880300715
HP:0002665HP:0002665Lymphoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA186973164785
HP:0002665HP:0002665Lymphoma1MLH1 CL E G H4292276300Turcot syndrome276300C0265325OMIM112037127120436
HP:0002665HP:0002665Lymphoma1MSH2 CL E G H4436276300Turcot syndrome276300C0265325OMIM112647325609309
HP:0002665HP:0002665Lymphoma1MSH6 CL E G H2956276300Turcot syndrome276300C0265325OMIM16027329600678
HP:0002665HP:0002665Lymphoma1MYD88 CL E G H461533226ORPHA177562602170
HP:0002665HP:0002665Lymphoma1NBN CL E G H4683251260Microcephaly, normal intelligence and immunodeficiency251260C0398791OMIM11487652602667
HP:0002665HP:0002665Lymphoma1NRAS CL E G H4893614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1147989164790
HP:0002665HP:0002665Lymphoma1PMS2 CL E G H5395276300Turcot syndrome276300C0265325OMIM13639122600259
HP:0002665HP:0002665Lymphoma1PNP CL E G H4860613179Purine-nucleoside phosphorylase deficiency613179C0268125OMIM1347892164050
HP:0002665HP:0002665Lymphoma1PRF1 CL E G H5551605027Non-Hodgkin lymphoma605027C0024305OMIM11849360170280
HP:0002665HP:0002665Lymphoma1RAD54B CL E G H25788605027Non-Hodgkin lymphoma605027C0024305OMIM1217228604289
HP:0002665HP:0002665Lymphoma1RAD54L CL E G H8438605027Non-Hodgkin lymphoma605027C0024305OMIM159826603615
HP:0002665HP:0002665Lymphoma1RB1 CL E G H5925180200Retinoblastoma180200C0035335OMIM111139884614041
HP:0002665HP:0002665Lymphoma1RUNX1 CL E G H861601399Familial platelet disorder with associated myeloid malignancy601399C1832388OMIM110510471151385
HP:0002665HP:0002665Lymphoma1SH2D1A CL E G H40682442ORPHA113110820300490
HP:0002665HP:0002665Lymphoma1SH2D1A CL E G H4068308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM113110820300490
HP:0002665HP:0002665Lymphoma1TNFRSF13B CL E G H23495240500Common variable immunodeficiency 2240500C3150354OMIM15018153604907
HP:0002665HP:0002665Lymphoma1TNFRSF13C CL E G H115650240500Common variable immunodeficiency 2240500C3150354OMIM1317755606269
HP:0002665HP:0002665Lymphoma1TP53 CL E G H7157524Acute megakaryoblastic leukemiaC0023462ORPHA154111998191170
HP:0002665HP:0002665Lymphoma1XIAP CL E G H3312442ORPHA199592300079
HP:0002665HP:0002665Lymphoma1XIAP CL E G H331308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM199592300079
HP:0002665HP:0002665Lymphoma1XRCC4 CL E G H751899812ORPHA11512831194363
HP:0002665HP:0002665Lymphoma2ATM CL E G H472208900Ataxia-telangiectasia syndrome208900C0004135OMIM11324795607585
HP:0002665HP:0002665Lymphoma2BCL2 CL E G H596545Adducted thumbs Dundar typeORPHA13990151430
HP:0002665HP:0002665Lymphoma2BCL6 CL E G H604545Adducted thumbs Dundar typeORPHA111001109565
HP:0002665HP:0002665Lymphoma2BLM CL E G H641210900Bloom syndrome210900C0005859OMIM11311058604610
HP:0002665HP:0002665Lymphoma2CASP10 CL E G H843605027Non-Hodgkin lymphoma605027C0024305OMIM191500601762
HP:0002665HP:0002665Lymphoma2CD19 CL E G H930240500Common variable immunodeficiency 2240500C3150354OMIM1101633107265
HP:0002665HP:0002665Lymphoma2CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA12431787600160
HP:0002665HP:0002665Lymphoma2CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA121316627604373
HP:0002665HP:0002665Lymphoma2CR2 CL E G H1380240500Common variable immunodeficiency 2240500C3150354OMIM1192336120650
HP:0002665HP:0002665Lymphoma2HLA-DRB1 CL E G H3123545Adducted thumbs Dundar typeORPHA1264948142857
HP:0002665HP:0002665Lymphoma2ICOS CL E G H29851240500Common variable immunodeficiency 2240500C3150354OMIM165351604558
HP:0002665HP:0002665Lymphoma2IGH CL E G H3492545Adducted thumbs Dundar typeORPHA15477146910
HP:0002665HP:0002665Lymphoma2ITK CL E G H3702613011Lymphoproliferative syndrome 1613011C3552634OMIM1146171186973
HP:0002665HP:0002665Lymphoma2KRAS CL E G H3845614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1456407190070
HP:0002665HP:0002665Lymphoma2LIG4 CL E G H398199812ORPHA1406601601837
HP:0002665HP:0002665Lymphoma2LYST CL E G H1130167ORPHA11021968606897
HP:0002665HP:0002665Lymphoma2MAGT1 CL E G H84061300853Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia300853C3275445OMIM11528880300715
HP:0002665HP:0002665Lymphoma2MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA186973164785
HP:0002665HP:0002665Lymphoma2MLH1 CL E G H4292276300Turcot syndrome276300C0265325OMIM112037127120436
HP:0002665HP:0002665Lymphoma2MSH2 CL E G H4436276300Turcot syndrome276300C0265325OMIM112647325609309
HP:0002665HP:0002665Lymphoma2MSH6 CL E G H2956276300Turcot syndrome276300C0265325OMIM16027329600678
HP:0002665HP:0002665Lymphoma2MYD88 CL E G H461533226ORPHA177562602170
HP:0002665HP:0002665Lymphoma2NBN CL E G H4683251260Microcephaly, normal intelligence and immunodeficiency251260C0398791OMIM11487652602667
HP:0002665HP:0002665Lymphoma2NRAS CL E G H4893614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1147989164790
HP:0002665HP:0002665Lymphoma2PMS2 CL E G H5395276300Turcot syndrome276300C0265325OMIM13639122600259
HP:0002665HP:0002665Lymphoma2PNP CL E G H4860613179Purine-nucleoside phosphorylase deficiency613179C0268125OMIM1347892164050
HP:0002665HP:0002665Lymphoma2PRF1 CL E G H5551605027Non-Hodgkin lymphoma605027C0024305OMIM11849360170280
HP:0002665HP:0002665Lymphoma2RAD54B CL E G H25788605027Non-Hodgkin lymphoma605027C0024305OMIM1217228604289
HP:0002665HP:0002665Lymphoma2RAD54L CL E G H8438605027Non-Hodgkin lymphoma605027C0024305OMIM159826603615
HP:0002665HP:0002665Lymphoma2RB1 CL E G H5925180200Retinoblastoma180200C0035335OMIM111139884614041
HP:0002665HP:0002665Lymphoma2RUNX1 CL E G H861601399Familial platelet disorder with associated myeloid malignancy601399C1832388OMIM110510471151385
HP:0002665HP:0002665Lymphoma2SH2D1A CL E G H40682442ORPHA113110820300490
HP:0002665HP:0002665Lymphoma2SH2D1A CL E G H4068308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM113110820300490
HP:0002665HP:0002665Lymphoma2TNFRSF13B CL E G H23495240500Common variable immunodeficiency 2240500C3150354OMIM15018153604907
HP:0002665HP:0002665Lymphoma2TNFRSF13C CL E G H115650240500Common variable immunodeficiency 2240500C3150354OMIM1317755606269
HP:0002665HP:0002665Lymphoma2TP53 CL E G H7157524Acute megakaryoblastic leukemiaC0023462ORPHA154111998191170
HP:0002665HP:0002665Lymphoma2XIAP CL E G H3312442ORPHA199592300079
HP:0002665HP:0002665Lymphoma2XIAP CL E G H331308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM199592300079
HP:0002665HP:0002665Lymphoma2XRCC4 CL E G H751899812ORPHA11512831194363
HP:0002665HP:0002665Lymphoma3ATM CL E G H472208900Ataxia-telangiectasia syndrome208900C0004135OMIM11324795607585
HP:0002665HP:0002665Lymphoma3BCL2 CL E G H596545Adducted thumbs Dundar typeORPHA13990151430
HP:0002665HP:0002665Lymphoma3BCL6 CL E G H604545Adducted thumbs Dundar typeORPHA111001109565
HP:0002665HP:0002665Lymphoma3BLM CL E G H641210900Bloom syndrome210900C0005859OMIM11311058604610
HP:0002665HP:0002665Lymphoma3CASP10 CL E G H843605027Non-Hodgkin lymphoma605027C0024305OMIM191500601762
HP:0002665HP:0002665Lymphoma3CD19 CL E G H930240500Common variable immunodeficiency 2240500C3150354OMIM1101633107265
HP:0002665HP:0002665Lymphoma3CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA12431787600160
HP:0002665HP:0002665Lymphoma3CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA121316627604373
HP:0002665HP:0002665Lymphoma3CR2 CL E G H1380240500Common variable immunodeficiency 2240500C3150354OMIM1192336120650
HP:0002665HP:0002665Lymphoma3HLA-DRB1 CL E G H3123545Adducted thumbs Dundar typeORPHA1264948142857
HP:0002665HP:0002665Lymphoma3ICOS CL E G H29851240500Common variable immunodeficiency 2240500C3150354OMIM165351604558
HP:0002665HP:0002665Lymphoma3IGH CL E G H3492545Adducted thumbs Dundar typeORPHA15477146910
HP:0002665HP:0002665Lymphoma3ITK CL E G H3702613011Lymphoproliferative syndrome 1613011C3552634OMIM1146171186973
HP:0002665HP:0002665Lymphoma3KRAS CL E G H3845614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1456407190070
HP:0002665HP:0002665Lymphoma3LIG4 CL E G H398199812ORPHA1406601601837
HP:0002665HP:0002665Lymphoma3LYST CL E G H1130167ORPHA11021968606897
HP:0002665HP:0002665Lymphoma3MAGT1 CL E G H84061300853Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia300853C3275445OMIM11528880300715
HP:0002665HP:0002665Lymphoma3MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA186973164785
HP:0002665HP:0002665Lymphoma3MLH1 CL E G H4292276300Turcot syndrome276300C0265325OMIM112037127120436
HP:0002665HP:0002665Lymphoma3MSH2 CL E G H4436276300Turcot syndrome276300C0265325OMIM112647325609309
HP:0002665HP:0002665Lymphoma3MSH6 CL E G H2956276300Turcot syndrome276300C0265325OMIM16027329600678
HP:0002665HP:0002665Lymphoma3MYD88 CL E G H461533226ORPHA177562602170
HP:0002665HP:0002665Lymphoma3NBN CL E G H4683251260Microcephaly, normal intelligence and immunodeficiency251260C0398791OMIM11487652602667
HP:0002665HP:0002665Lymphoma3NRAS CL E G H4893614470RAS-associated autoimmune leukoproliferative disorder614470C2674723OMIM1147989164790
HP:0002665HP:0002665Lymphoma3PMS2 CL E G H5395276300Turcot syndrome276300C0265325OMIM13639122600259
HP:0002665HP:0002665Lymphoma3PNP CL E G H4860613179Purine-nucleoside phosphorylase deficiency613179C0268125OMIM1347892164050
HP:0002665HP:0002665Lymphoma3PRF1 CL E G H5551605027Non-Hodgkin lymphoma605027C0024305OMIM11849360170280
HP:0002665HP:0002665Lymphoma3RAD54B CL E G H25788605027Non-Hodgkin lymphoma605027C0024305OMIM1217228604289
HP:0002665HP:0002665Lymphoma3RAD54L CL E G H8438605027Non-Hodgkin lymphoma605027C0024305OMIM159826603615
HP:0002665HP:0002665Lymphoma3RB1 CL E G H5925180200Retinoblastoma180200C0035335OMIM111139884614041
HP:0002665HP:0002665Lymphoma3RUNX1 CL E G H861601399Familial platelet disorder with associated myeloid malignancy601399C1832388OMIM110510471151385
HP:0002665HP:0002665Lymphoma3SH2D1A CL E G H40682442ORPHA113110820300490
HP:0002665HP:0002665Lymphoma3SH2D1A CL E G H4068308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM113110820300490
HP:0002665HP:0002665Lymphoma3TNFRSF13B CL E G H23495240500Common variable immunodeficiency 2240500C3150354OMIM15018153604907
HP:0002665HP:0002665Lymphoma3TNFRSF13C CL E G H115650240500Common variable immunodeficiency 2240500C3150354OMIM1317755606269
HP:0002665HP:0002665Lymphoma3TP53 CL E G H7157524Acute megakaryoblastic leukemiaC0023462ORPHA154111998191170
HP:0002665HP:0002665Lymphoma3XIAP CL E G H3312442ORPHA199592300079
HP:0002665HP:0002665Lymphoma3XIAP CL E G H331308240Lymphoproliferative syndrome 1, X-linked308240C1868674OMIM199592300079
HP:0002665HP:0002665Lymphoma3XRCC4 CL E G H751899812ORPHA11512831194363
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002665HP:0002665Lymphoma0ADA CL E G H10039041ORPHA096186608958
HP:0002665HP:0002665Lymphoma0BLM CL E G H641125ORPHA01311058604610
HP:0002665HP:0002665Lymphoma0CD19 CL E G H9301572ORPHA0101633107265
HP:0002665HP:0002665Lymphoma0CD27 CL E G H939615122Lymphoproliferative syndrome 2615122C3554540OMIM0811922186711
HP:0002665HP:0002665Lymphoma0CD81 CL E G H9751572ORPHA021701186845
HP:0002665HP:0002665Lymphoma0CHD7 CL E G H5563639041ORPHA088420626608892
HP:0002665HP:0002665Lymphoma0CR2 CL E G H13801572ORPHA0192336120650
HP:0002665HP:0002665Lymphoma0CTC1 CL E G H801691775Chromosome 4, monosomy 4p14 p16CN036837ORPHA03426169613129
HP:0002665HP:0002665Lymphoma0DCLRE1C CL E G H6442139041ORPHA09117642605988
HP:0002665HP:0002665Lymphoma0DKC1 CL E G H17361775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0752890300126
HP:0002665HP:0002665Lymphoma0DNASE1L3 CL E G H177636412ORPHA0102959602244
HP:0002665HP:0002665Lymphoma0ICOS CL E G H298511572ORPHA065351604558
HP:0002665HP:0002665Lymphoma0IL2RG CL E G H356139041ORPHA02506010308380
HP:0002665HP:0002665Lymphoma0IL7R CL E G H357539041ORPHA0596024146661
HP:0002665HP:0002665Lymphoma0KIF11 CL E G H38322526ORPHA0706388148760
HP:0002665HP:0002665Lymphoma0LIG4 CL E G H398139041ORPHA0406601601837
HP:0002665HP:0002665Lymphoma0LIG4 CL E G H3981235ORPHA0406601601837
HP:0002665HP:0002665Lymphoma0MS4A1 CL E G H9311572ORPHA027315112210
HP:0002665HP:0002665Lymphoma0MYD88 CL E G H4615153600Waldenstrom macroglobulinemia153600C1835192OMIM077562602170
HP:0002665HP:0002665Lymphoma0NFKB1 CL E G H47901572ORPHA0367794164011
HP:0002665HP:0002665Lymphoma0NFKB2 CL E G H47911572ORPHA0117795164012
HP:0002665HP:0002665Lymphoma0NHP2 CL E G H556511775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0314377606470
HP:0002665HP:0002665Lymphoma0NOP10 CL E G H555051775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0114378606471
HP:0002665HP:0002665Lymphoma0NSUN2 CL E G H54888235ORPHA0725994610916
HP:0002665HP:0002665Lymphoma0PARN CL E G H50731775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0298609604212
HP:0002665HP:0002665Lymphoma0PRKCD CL E G H55801572ORPHA069399176977
HP:0002665HP:0002665Lymphoma0PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA06589588601728
HP:0002665HP:0002665Lymphoma0RAG1 CL E G H589639041ORPHA01879831179615
HP:0002665HP:0002665Lymphoma0RAG2 CL E G H589739041ORPHA0849832179616
HP:0002665HP:0002665Lymphoma0RECQL4 CL E G H94011225ORPHA01229949603780
HP:0002665HP:0002665Lymphoma0RMRP CL E G H602339041ORPHA012310031157660
HP:0002665HP:0002665Lymphoma0RMRP CL E G H6023250250Metaphyseal chondrodysplasia, McKusick type250250C0220748OMIM012310031157660
HP:0002665HP:0002665Lymphoma0RTEL1 CL E G H517501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA05415888608833
HP:0002665HP:0002665Lymphoma0STAT3 CL E G H67742314ORPHA015511364102582
HP:0002665HP:0002665Lymphoma0TERC CL E G H70121775Chromosome 4, monosomy 4p14 p16CN036837ORPHA07411727602322
HP:0002665HP:0002665Lymphoma0TERT CL E G H70151775Chromosome 4, monosomy 4p14 p16CN036837ORPHA017311730187270
HP:0002665HP:0002665Lymphoma0TINF2 CL E G H262771775Chromosome 4, monosomy 4p14 p16CN036837ORPHA04211824604319
HP:0002665HP:0002665Lymphoma0TNFRSF13B CL E G H234951572ORPHA05018153604907
HP:0002665HP:0002665Lymphoma0TNFRSF13C CL E G H1156501572ORPHA0317755606269
HP:0002665HP:0002665Lymphoma0TNFSF12 CL E G H87421572ORPHA0111927602695
HP:0002665HP:0002665Lymphoma0TP63 CL E G H86261896Dominant cleft palateORPHA012815979603273
HP:0002665HP:0002665Lymphoma0USB1 CL E G H796501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA02225792613276
HP:0002665HP:0002665Lymphoma0WAS CL E G H7454906ORPHA044112731300392
HP:0002665HP:0002665Lymphoma0WIPF1 CL E G H7456906ORPHA0312736602357
HP:0002665HP:0002665Lymphoma0WRAP53 CL E G H551351775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0725522612661
HP:0002665HP:0002665Lymphoma1ADA CL E G H10039041ORPHA096186608958
HP:0002665HP:0002665Lymphoma1BLM CL E G H641125ORPHA01311058604610
HP:0002665HP:0002665Lymphoma1CD19 CL E G H9301572ORPHA0101633107265
HP:0002665HP:0002665Lymphoma1CD27 CL E G H939615122Lymphoproliferative syndrome 2615122C3554540OMIM0811922186711
HP:0002665HP:0002665Lymphoma1CD81 CL E G H9751572ORPHA021701186845
HP:0002665HP:0002665Lymphoma1CHD7 CL E G H5563639041ORPHA088420626608892
HP:0002665HP:0002665Lymphoma1CR2 CL E G H13801572ORPHA0192336120650
HP:0002665HP:0002665Lymphoma1CTC1 CL E G H801691775Chromosome 4, monosomy 4p14 p16CN036837ORPHA03426169613129
HP:0002665HP:0002665Lymphoma1DCLRE1C CL E G H6442139041ORPHA09117642605988
HP:0002665HP:0002665Lymphoma1DKC1 CL E G H17361775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0752890300126
HP:0002665HP:0002665Lymphoma1DNASE1L3 CL E G H177636412ORPHA0102959602244
HP:0002665HP:0002665Lymphoma1ICOS CL E G H298511572ORPHA065351604558
HP:0002665HP:0002665Lymphoma1IL2RG CL E G H356139041ORPHA02506010308380
HP:0002665HP:0002665Lymphoma1IL7R CL E G H357539041ORPHA0596024146661
HP:0002665HP:0002665Lymphoma1KIF11 CL E G H38322526ORPHA0706388148760
HP:0002665HP:0002665Lymphoma1LIG4 CL E G H398139041ORPHA0406601601837
HP:0002665HP:0002665Lymphoma1LIG4 CL E G H3981235ORPHA0406601601837
HP:0002665HP:0002665Lymphoma1MS4A1 CL E G H9311572ORPHA027315112210
HP:0002665HP:0002665Lymphoma1MYD88 CL E G H4615153600Waldenstrom macroglobulinemia153600C1835192OMIM077562602170
HP:0002665HP:0002665Lymphoma1NFKB1 CL E G H47901572ORPHA0367794164011
HP:0002665HP:0002665Lymphoma1NFKB2 CL E G H47911572ORPHA0117795164012
HP:0002665HP:0002665Lymphoma1NHP2 CL E G H556511775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0314377606470
HP:0002665HP:0002665Lymphoma1NOP10 CL E G H555051775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0114378606471
HP:0002665HP:0002665Lymphoma1NSUN2 CL E G H54888235ORPHA0725994610916
HP:0002665HP:0002665Lymphoma1PARN CL E G H50731775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0298609604212
HP:0002665HP:0002665Lymphoma1PRKCD CL E G H55801572ORPHA069399176977
HP:0002665HP:0002665Lymphoma1PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA06589588601728
HP:0002665HP:0002665Lymphoma1RAG1 CL E G H589639041ORPHA01879831179615
HP:0002665HP:0002665Lymphoma1RAG2 CL E G H589739041ORPHA0849832179616
HP:0002665HP:0002665Lymphoma1RECQL4 CL E G H94011225ORPHA01229949603780
HP:0002665HP:0002665Lymphoma1RMRP CL E G H602339041ORPHA012310031157660
HP:0002665HP:0002665Lymphoma1RMRP CL E G H6023250250Metaphyseal chondrodysplasia, McKusick type250250C0220748OMIM012310031157660
HP:0002665HP:0002665Lymphoma1RTEL1 CL E G H517501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA05415888608833
HP:0002665HP:0002665Lymphoma1STAT3 CL E G H67742314ORPHA015511364102582
HP:0002665HP:0002665Lymphoma1TERC CL E G H70121775Chromosome 4, monosomy 4p14 p16CN036837ORPHA07411727602322
HP:0002665HP:0002665Lymphoma1TERT CL E G H70151775Chromosome 4, monosomy 4p14 p16CN036837ORPHA017311730187270
HP:0002665HP:0002665Lymphoma1TINF2 CL E G H262771775Chromosome 4, monosomy 4p14 p16CN036837ORPHA04211824604319
HP:0002665HP:0002665Lymphoma1TNFRSF13B CL E G H234951572ORPHA05018153604907
HP:0002665HP:0002665Lymphoma1TNFRSF13C CL E G H1156501572ORPHA0317755606269
HP:0002665HP:0002665Lymphoma1TNFSF12 CL E G H87421572ORPHA0111927602695
HP:0002665HP:0002665Lymphoma1TP63 CL E G H86261896Dominant cleft palateORPHA012815979603273
HP:0002665HP:0002665Lymphoma1USB1 CL E G H796501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA02225792613276
HP:0002665HP:0002665Lymphoma1WAS CL E G H7454906ORPHA044112731300392
HP:0002665HP:0002665Lymphoma1WIPF1 CL E G H7456906ORPHA0312736602357
HP:0002665HP:0002665Lymphoma1WRAP53 CL E G H551351775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0725522612661
HP:0002665HP:0002665Lymphoma2ADA CL E G H10039041ORPHA096186608958
HP:0002665HP:0002665Lymphoma2BLM CL E G H641125ORPHA01311058604610
HP:0002665HP:0002665Lymphoma2CD19 CL E G H9301572ORPHA0101633107265
HP:0002665HP:0002665Lymphoma2CD27 CL E G H939615122Lymphoproliferative syndrome 2615122C3554540OMIM0811922186711
HP:0002665HP:0002665Lymphoma2CD81 CL E G H9751572ORPHA021701186845
HP:0002665HP:0002665Lymphoma2CHD7 CL E G H5563639041ORPHA088420626608892
HP:0002665HP:0002665Lymphoma2CR2 CL E G H13801572ORPHA0192336120650
HP:0002665HP:0002665Lymphoma2CTC1 CL E G H801691775Chromosome 4, monosomy 4p14 p16CN036837ORPHA03426169613129
HP:0002665HP:0002665Lymphoma2DCLRE1C CL E G H6442139041ORPHA09117642605988
HP:0002665HP:0002665Lymphoma2DKC1 CL E G H17361775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0752890300126
HP:0002665HP:0002665Lymphoma2DNASE1L3 CL E G H177636412ORPHA0102959602244
HP:0002665HP:0002665Lymphoma2ICOS CL E G H298511572ORPHA065351604558
HP:0002665HP:0002665Lymphoma2IL2RG CL E G H356139041ORPHA02506010308380
HP:0002665HP:0002665Lymphoma2IL7R CL E G H357539041ORPHA0596024146661
HP:0002665HP:0002665Lymphoma2KIF11 CL E G H38322526ORPHA0706388148760
HP:0002665HP:0002665Lymphoma2LIG4 CL E G H398139041ORPHA0406601601837
HP:0002665HP:0002665Lymphoma2LIG4 CL E G H3981235ORPHA0406601601837
HP:0002665HP:0002665Lymphoma2MS4A1 CL E G H9311572ORPHA027315112210
HP:0002665HP:0002665Lymphoma2MYD88 CL E G H4615153600Waldenstrom macroglobulinemia153600C1835192OMIM077562602170
HP:0002665HP:0002665Lymphoma2NFKB1 CL E G H47901572ORPHA0367794164011
HP:0002665HP:0002665Lymphoma2NFKB2 CL E G H47911572ORPHA0117795164012
HP:0002665HP:0002665Lymphoma2NHP2 CL E G H556511775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0314377606470
HP:0002665HP:0002665Lymphoma2NOP10 CL E G H555051775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0114378606471
HP:0002665HP:0002665Lymphoma2NSUN2 CL E G H54888235ORPHA0725994610916
HP:0002665HP:0002665Lymphoma2PARN CL E G H50731775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0298609604212
HP:0002665HP:0002665Lymphoma2PRKCD CL E G H55801572ORPHA069399176977
HP:0002665HP:0002665Lymphoma2PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA06589588601728
HP:0002665HP:0002665Lymphoma2RAG1 CL E G H589639041ORPHA01879831179615
HP:0002665HP:0002665Lymphoma2RAG2 CL E G H589739041ORPHA0849832179616
HP:0002665HP:0002665Lymphoma2RECQL4 CL E G H94011225ORPHA01229949603780
HP:0002665HP:0002665Lymphoma2RMRP CL E G H602339041ORPHA012310031157660
HP:0002665HP:0002665Lymphoma2RMRP CL E G H6023250250Metaphyseal chondrodysplasia, McKusick type250250C0220748OMIM012310031157660
HP:0002665HP:0002665Lymphoma2RTEL1 CL E G H517501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA05415888608833
HP:0002665HP:0002665Lymphoma2STAT3 CL E G H67742314ORPHA015511364102582
HP:0002665HP:0002665Lymphoma2TERC CL E G H70121775Chromosome 4, monosomy 4p14 p16CN036837ORPHA07411727602322
HP:0002665HP:0002665Lymphoma2TERT CL E G H70151775Chromosome 4, monosomy 4p14 p16CN036837ORPHA017311730187270
HP:0002665HP:0002665Lymphoma2TINF2 CL E G H262771775Chromosome 4, monosomy 4p14 p16CN036837ORPHA04211824604319
HP:0002665HP:0002665Lymphoma2TNFRSF13B CL E G H234951572ORPHA05018153604907
HP:0002665HP:0002665Lymphoma2TNFRSF13C CL E G H1156501572ORPHA0317755606269
HP:0002665HP:0002665Lymphoma2TNFSF12 CL E G H87421572ORPHA0111927602695
HP:0002665HP:0002665Lymphoma2TP63 CL E G H86261896Dominant cleft palateORPHA012815979603273
HP:0002665HP:0002665Lymphoma2USB1 CL E G H796501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA02225792613276
HP:0002665HP:0002665Lymphoma2WAS CL E G H7454906ORPHA044112731300392
HP:0002665HP:0002665Lymphoma2WIPF1 CL E G H7456906ORPHA0312736602357
HP:0002665HP:0002665Lymphoma2WRAP53 CL E G H551351775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0725522612661
HP:0002665HP:0002665Lymphoma3ADA CL E G H10039041ORPHA096186608958
HP:0002665HP:0002665Lymphoma3BLM CL E G H641125ORPHA01311058604610
HP:0002665HP:0002665Lymphoma3CD19 CL E G H9301572ORPHA0101633107265
HP:0002665HP:0002665Lymphoma3CD27 CL E G H939615122Lymphoproliferative syndrome 2615122C3554540OMIM0811922186711
HP:0002665HP:0002665Lymphoma3CD81 CL E G H9751572ORPHA021701186845
HP:0002665HP:0002665Lymphoma3CHD7 CL E G H5563639041ORPHA088420626608892
HP:0002665HP:0002665Lymphoma3CR2 CL E G H13801572ORPHA0192336120650
HP:0002665HP:0002665Lymphoma3CTC1 CL E G H801691775Chromosome 4, monosomy 4p14 p16CN036837ORPHA03426169613129
HP:0002665HP:0002665Lymphoma3DCLRE1C CL E G H6442139041ORPHA09117642605988
HP:0002665HP:0002665Lymphoma3DKC1 CL E G H17361775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0752890300126
HP:0002665HP:0002665Lymphoma3DNASE1L3 CL E G H177636412ORPHA0102959602244
HP:0002665HP:0002665Lymphoma3ICOS CL E G H298511572ORPHA065351604558
HP:0002665HP:0002665Lymphoma3IL2RG CL E G H356139041ORPHA02506010308380
HP:0002665HP:0002665Lymphoma3IL7R CL E G H357539041ORPHA0596024146661
HP:0002665HP:0002665Lymphoma3KIF11 CL E G H38322526ORPHA0706388148760
HP:0002665HP:0002665Lymphoma3LIG4 CL E G H398139041ORPHA0406601601837
HP:0002665HP:0002665Lymphoma3LIG4 CL E G H3981235ORPHA0406601601837
HP:0002665HP:0002665Lymphoma3MS4A1 CL E G H9311572ORPHA027315112210
HP:0002665HP:0002665Lymphoma3MYD88 CL E G H4615153600Waldenstrom macroglobulinemia153600C1835192OMIM077562602170
HP:0002665HP:0002665Lymphoma3NFKB1 CL E G H47901572ORPHA0367794164011
HP:0002665HP:0002665Lymphoma3NFKB2 CL E G H47911572ORPHA0117795164012
HP:0002665HP:0002665Lymphoma3NHP2 CL E G H556511775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0314377606470
HP:0002665HP:0002665Lymphoma3NOP10 CL E G H555051775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0114378606471
HP:0002665HP:0002665Lymphoma3NSUN2 CL E G H54888235ORPHA0725994610916
HP:0002665HP:0002665Lymphoma3PARN CL E G H50731775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0298609604212
HP:0002665HP:0002665Lymphoma3PRKCD CL E G H55801572ORPHA069399176977
HP:0002665HP:0002665Lymphoma3PTEN CL E G H5728109Bannayan-Riley-Ruvalcaba syndromeC0265326ORPHA06589588601728
HP:0002665HP:0002665Lymphoma3RAG1 CL E G H589639041ORPHA01879831179615
HP:0002665HP:0002665Lymphoma3RAG2 CL E G H589739041ORPHA0849832179616
HP:0002665HP:0002665Lymphoma3RECQL4 CL E G H94011225ORPHA01229949603780
HP:0002665HP:0002665Lymphoma3RMRP CL E G H602339041ORPHA012310031157660
HP:0002665HP:0002665Lymphoma3RMRP CL E G H6023250250Metaphyseal chondrodysplasia, McKusick type250250C0220748OMIM012310031157660
HP:0002665HP:0002665Lymphoma3RTEL1 CL E G H517501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA05415888608833
HP:0002665HP:0002665Lymphoma3STAT3 CL E G H67742314ORPHA015511364102582
HP:0002665HP:0002665Lymphoma3TERC CL E G H70121775Chromosome 4, monosomy 4p14 p16CN036837ORPHA07411727602322
HP:0002665HP:0002665Lymphoma3TERT CL E G H70151775Chromosome 4, monosomy 4p14 p16CN036837ORPHA017311730187270
HP:0002665HP:0002665Lymphoma3TINF2 CL E G H262771775Chromosome 4, monosomy 4p14 p16CN036837ORPHA04211824604319
HP:0002665HP:0002665Lymphoma3TNFRSF13B CL E G H234951572ORPHA05018153604907
HP:0002665HP:0002665Lymphoma3TNFRSF13C CL E G H1156501572ORPHA0317755606269
HP:0002665HP:0002665Lymphoma3TNFSF12 CL E G H87421572ORPHA0111927602695
HP:0002665HP:0002665Lymphoma3TP63 CL E G H86261896Dominant cleft palateORPHA012815979603273
HP:0002665HP:0002665Lymphoma3USB1 CL E G H796501775Chromosome 4, monosomy 4p14 p16CN036837ORPHA02225792613276
HP:0002665HP:0002665Lymphoma3WAS CL E G H7454906ORPHA044112731300392
HP:0002665HP:0002665Lymphoma3WIPF1 CL E G H7456906ORPHA0312736602357
HP:0002665HP:0002665Lymphoma3WRAP53 CL E G H551351775Chromosome 4, monosomy 4p14 p16CN036837ORPHA0725522612661


Genes (88) :AAGAB ADA ATM BCL10 BCL2 BCL6 BIRC3 BLM CASP10 CCND1 CD19 CD27 CD28 CD81 CDKN2A CHD7 CHEK2 COL14A1 CR2 CTC1 CTLA4 DCLRE1C DKC1 DNASE1L3 FOXP1 HLA-DRB1 ICOS IGH IL2RG IL7R ITK KIF11 KIT KRAS LIG4 LYST MAGT1 MALT1 MDM2 MLH1 MS4A1 MSH2 MSH6 MYC MYD88 NBN NFKB1 NFKB2 NHP2 NOP10 NRAS NSUN2 NTHL1 PARN PIK3R1 PMS2 PNP PRF1 PRKCD PTEN RAD54B RAD54L RAG1 RAG2 RB1 RECQL4 RMRP RNF43 RTEL1 RUNX1 SH2D1A STAT3 TCF4 TERC TERT TINF2 TNFRSF13B TNFRSF13C TNFRSF1B TNFSF12 TP53 TP63 USB1 WAS WIPF1 WRAP53 XIAP XRCC4

Diseases (49) :39041 208900 545 125 210900 605027 1572 240500 615122 524 1775 36412 613011 2526 614470 99812 235 167 300853 276300 33226 153600 251260 613179 109 180200 1225 250250 601399 2442 308240 2314 1896 906 79501 137245 305000 98849 454840 157798 2896 102700 52416 52417 113970 647 616005 2584 3162
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is June 2019 release.